These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33469283)

  • 1. Erratum: Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer [Corrigendum].
    Int J Nanomedicine; 2021; 16():237-238. PubMed ID: 33469283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer.
    Lv Y; Jun Y; Tang Z; Li X; Tao M; Zhang Z; Liu L; Sun S; Wang Q; Luo C; Zhang L
    Int J Nanomedicine; 2020; 15():10075-10084. PubMed ID: 33335395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum].
    Int J Nanomedicine; 2021; 16():469-470. PubMed ID: 33488081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum].
    Int J Nanomedicine; 2023; 18():4447-4448. PubMed ID: 37555191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC [Corrigendum].
    Int J Nanomedicine; 2021; 16():8067-8068. PubMed ID: 34938073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Folic Acid-Targeted Disulfide-Based Cross-Linking Micelle for Enhanced Drug Encapsulation Stability and Site-Specific Drug Delivery Against Tumors [Corrigendum].
    Int J Nanomedicine; 2021; 16():7683-7684. PubMed ID: 34848954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum].
    Int J Nanomedicine; 2019; 14():8753-8754. PubMed ID: 31806969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum].
    Int J Nanomedicine; 2021; 16():5099. PubMed ID: 34349509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer [Corrigendum].
    Int J Nanomedicine; 2021; 16():3121-3123. PubMed ID: 33976545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum].
    Int J Nanomedicine; 2020; 15():5179. PubMed ID: 32801684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum].
    Int J Nanomedicine; 2020; 15():839. PubMed ID: 32103940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Inhibition of Proliferation and Migration of Tumor Cells Through Phenylboronic Acid-Functionalized Polyamidoamine-Mediated Delivery of a Therapeutic DNAzyme Dz13 [Corrigendum].
    Int J Nanomedicine; 2021; 16():8117-8119. PubMed ID: 34949920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Doxorubicin-Loaded Poly (Lactic-Co-Glycolic Acid) Nanoparticles Coated with Chitosan/Alginate by Layer by Layer Technology for Antitumor Applications [Corrigendum].
    Int J Nanomedicine; 2021; 16():4187. PubMed ID: 34177263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: A High Bioavailability and Sustained-Release Nano-Delivery System for Nintedanib Based on Electrospray Technology [Corrigendum].
    Int J Nanomedicine; 2021; 16():4179-4181. PubMed ID: 34168448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Construction and in vivo/in vitro Evaluation of a Nanoporous Ion-Responsive Targeted Drug Delivery System for Recombinant Human Interferon α-2b Delivery [Corrigendum].
    Int J Nanomedicine; 2021; 16():4191-4192. PubMed ID: 34168451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Potential Efficacy of Herbal Medicine-Derived Carbon Dots in the Treatment of Diseases: From Mechanism to Clinic [Corrigendum].
    Int J Nanomedicine; 2024; 19():4043-4044. PubMed ID: 38736652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum].
    Int J Nanomedicine; 2021; 16():7283-7284. PubMed ID: 34737565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum].
    Int J Nanomedicine; 2019; 14():7919. PubMed ID: 31632008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum].
    Int J Nanomedicine; 2020; 15():8293-8294. PubMed ID: 33149576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: pH-Responsive Artesunate Polymer Prodrugs with Enhanced Ablation Effect on Rodent Xenograft Colon Cancer [Corrigendum].
    Int J Nanomedicine; 2020; 15():3717-3718. PubMed ID: 32581532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.